Company intelligence / Profile preview

Smoore

Shenzhen, Guangdong, China

Ownership: Private
Employees: ~20000
Development stage: Other

Overview

Smoore is the world's largest manufacturer of vaping devices and atomization technology solutions. It operates globally, IPO’d in 2020 on the Hong Kong Stock Exchange, and focuses on developing atomization tech for vaping, healthcare inhaled drug delivery, and beauty sectors. Its devices and components are commercialized. While it develops healthcare atomization devices (e.g., inhalers), it does not develop drugs or therapeutic programs. No pharmaceutical clinical results are reported, and it is not a traditional life sciences pipeline company.

Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Smoore.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Smoore.

Explore the full profile